针对阿尔茨海默病中的代谢失调:一种潜在的治疗策略
Nivedita Barnwal1, Sonal Dubey1, Prashant Tiwari1
1College of Pharmaceutical Sciences, Dayanand Sagar University, Harohalli, Bengaluru- 562112, India.
Current drug metabolism
|September 24, 2025
概括
代谢功能障碍对阿尔茨海默病 (AD) 的进展有显著的贡献. 准代谢途径提供了一个有希望的治疗策略,可以减缓神经退行并改善阿兹海默症患者的治疗结果.
科学领域:
- 神经科学是一个神经科学.
- 代谢障碍 代谢障碍 代谢障碍
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特点是认知能力下降和神经病理学.
- 代谢功能障碍,包括葡萄糖代谢受损和线粒体问题,越来越被认为是AD病变的关键因素.
- 这些代谢干扰导致神经元能量缺陷,突触功能障碍和神经退行.
研究的目的:
- 审查针对阿尔茨海默氏症中代谢途径的治疗潜力.
- 探索代谢失调如何影响AD病理和认知缺陷.
- 突出基于代谢重编程的AD新型治疗策略.
主要方法:
- 对研究研究AD的代谢功能障碍的文献综述.
- 对代谢干预措施的临床前和早期临床数据的分析.
- 在AD中探索代谢途径,神经炎症和氧化应激之间的相互作用.
主要成果:
- 关键的代谢干扰,如胰岛素抵抗和线粒体效率低下,与阿尔茨海默病有关.
- 包括胰岛素敏感剂,性饮食和抗氧化剂在内的治疗方法显示出有前途.
- 调节脂质代谢和解决神经炎症是潜在的干预策略.
结论:
- 准代谢途径代表了AD的新和整合性治疗策略.
- 解决代谢和炎症途径的多方面的方法至关重要.
- 根据个体代谢特征量身定制的精密药物可以提高AD的治疗疗效.
更多相关视频
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
28.0K
10:46Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
11.7K
相关概念视频
01:22Alzheimer's Disease: Treatment
824
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K